bioMérieux
A global leader in in vitro diagnostics for clinical and industrial applications.
BIM | PA
Overview
Corporate Details
- ISIN(s):
- FR0013280286 (+13 more)
- LEI:
- 549300AK8Y0LBIQ4T071
- Country:
- France
- Address:
- 376 CHE DE L'ORME, 69280 MARCY-L'ETOILE
- Website:
- https://www.biomerieux.com/
- Sector:
- Manufacturing
Description
bioMérieux is a global leader in the field of in vitro diagnostics, providing solutions that determine the source of disease and contamination. The company develops and manufactures diagnostic systems, reagents, and software for both clinical and industrial applications. In the clinical sector, its products are used for diagnosing infectious diseases, managing sepsis, combating antimicrobial resistance, and supporting cancer screening and cardiovascular emergencies. For industrial markets, bioMérieux offers microbiological control solutions to ensure the safety and quality of agri-food, pharmaceutical, and cosmetic products. These technologies provide rapid and reliable data to help healthcare professionals and industrial quality control managers make critical decisions that improve patient outcomes and ensure consumer safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-19 07:18 |
Closing of the acquisition of Specific Diagnostics
|
English | PDF • 219.6 KB | ||
| 2022-05-19 07:18 |
Finalisation de l’acquisition de Specific Diagnostics
|
French | PDF • 328.4 KB | ||
| 2022-05-13 07:05 |
bioMérieux annonce le marquage CE de tests VIDAS® pour le diagnostic du virus…
|
French | PDF • 406.2 KB | ||
| 2022-05-13 07:05 |
bioMérieux announces the CE marking of VIDAS® tests for Chikungunya virus diagn…
|
English | PDF • 402.7 KB | ||
| 2022-05-12 18:01 |
Increase in resources allocated to the liquidity contract with Natixis ODDO BHF
|
English | PDF • 567.2 KB | ||
| 2022-05-12 18:01 |
Augmentation de moyens au contrat de liquidité avec Natixis ODDO BHF
|
French | PDF • 849.1 KB | ||
| 2022-05-04 07:01 |
bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection …
|
English | PDF • 441.1 KB | ||
| 2022-05-03 09:29 |
Avril 2022 - Déclaration sur le nombre d'actions composant le capital social et…
|
French | PDF • 206.1 KB | ||
| 2022-04-13 09:52 |
AG 2022 - Avis de mise à disposition des documents préparatoires à l'Assemblée …
|
French | PDF • 203.5 KB | ||
| 2022-04-12 07:25 |
bioMérieux strengthens its commitment to fight antimicrobial resistance with th…
|
English | PDF • 495.0 KB | ||
| 2022-04-12 07:25 |
bioMérieux renforce son engagement dans la lutte contre la résistance aux antib…
|
French | PDF • 425.0 KB | ||
| 2022-04-11 18:06 |
bioMérieux – First-Quarter 2022 Business Review
|
English | PDF • 352.9 KB | ||
| 2022-04-11 18:06 |
bioMérieux – Information financière du 1er trimestre 2022
|
French | PDF • 254.9 KB | ||
| 2022-04-04 16:26 |
Mars 2022 - Déclaration sur le nombre d'actions composant le capital social et …
|
French | PDF • 205.4 KB | ||
| 2022-03-21 10:21 |
Release of the Universal Registration Document including the Annual Financial R…
|
English | PDF • 199.8 KB |
Automate Your Workflow. Get a real-time feed of all bioMérieux filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for bioMérieux
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for bioMérieux via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-04 | N/A | Other | Sell | 1,432 | 137,517.82 EUR |
| 2023-09-04 | N/A | Other | Sell | 1,253 | 120,328.10 EUR |
| 2023-09-01 | N/A | Other | Other | 2,900 | N/A |
| 2023-06-23 | N/A | Other | Other | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 300 | 23,193.00 EUR |
| 2023-06-23 | N/A | Other | Buy | 25 | 1,932.75 EUR |
| 2023-03-23 | N/A | Other | Sell | 16,500 | 1,650,415.80 EUR |
Peer Companies
